Chronic Erythropoietin Treatment Decreases Post-Infarct Myocardial Damage in Rats without Venous Thrombogenic Effect

Publisher： Karger

E-ISSN： 1421-9751|112|2|129-134

ISSN： 0008-6312

Source： Cardiology, Vol.112, Iss.2, 2008-07, pp. : 129-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early and chronic captopril or Losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in rats

By Martinez L.A.   Villalobos-Molina R.  

Archives of Medical Research, Vol. 34, Iss. 5, 2003-09 ,pp. : 357-361

Elsevier

Access to resources Recommend Favorite

Recombinant Human Erythropoietin in the Treatment of Chronic Anemia of Cancer

By  

Acta Haematologica, Vol. 100, Iss. 2, 1998-10 ,pp. : 115-115

Karger

Access to resources Recommend Favorite

Erythropoietin Decreases the Occurrence of Myocardial Fibrosis by Inhibiting the NADPH-ERK-NF-κB Pathway

By  

Cardiology, Vol. 133, Iss. 2, 2016-0 ,pp. : 97-108

Karger

Access to resources Recommend Favorite

Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats

By  

International Journal of Molecular Medicine, Vol. 35, Iss. 3, 2015-01 ,pp. : 829-838

Spandidos Publications

Access to resources Recommend Favorite

Apligraf Treatment of Venous Ulcers and Other Chronic Wounds

By  

THE JOURNAL OF DERMATOLOGY, Vol. 25, Iss. 12, 1998-12 ,pp. : 812-817

John Wiley & Sons Inc

Access to resources Recommend Favorite